MAPT and early-onset autosomal dominant Alzheimer disease: A study by Yang et al. 62 demonstrated mitigation of tau deposits by ex vivo-expanded Tregs, suggesting that Tregs can play a role in reducing tau Alzheimer’s disease pathologies.